Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team
Regulatory press release

Ortoma Submits Application for CE-mark of Spine Module

Ortoma
Read the release

Ortoma has submitted a regulatory application for CE-mark of its spine module to be included in the platform Ortoma Treatment Solution (OTS). The spine module is a pre-operative planning solution for spine surgery. The OTS platform is a surgical system that is assisted by AI (Artificial Intelligence) for improved accuracy, efficiency and surgical outcome.
 

The submission will be reviewed by the Notified Body. Their CE assessment is expected to be completed during the second quarter of 2021. After obtaining the CE-mark, the product will be available for use clinically.

"The development of the advanced spine module for OTS demonstrates how powerful our core technology is. Experienced spine surgeons, including our chairman of the Board of Directors, prof. Gunnar Németh, supported the development team. With OTS Spine we will reach our initial goal to advance pre-operative planning of spine surgery to a higher level of accuracy, efficiency and standard of care" says Linus Byström, CEO of Ortoma.

 

A CE-marked spine module significantly extends the market potential of OTS. The global spine surgery market is estimated to reach $14.3 billion in 2022 from $10.8 billion in 2017, at a CAGR of 5.8%. Factors driving the growth of the industry include growing incidence of spinal disorders, accessibility of minimally invasive spine surgical techniques, and the increase of  Minimally Invasive Spine Surgery in health care centers. The spine module is built on the OTS platform that is assisted by AI, and is designed to address the challenges of the spine surgery market.

Ortoma - Improved Performance

Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team